Supporting evidence-informed policy: a multidimensional impact analysis of health technology assessment in Thailand
Frontiers in Public Health · 08.07.2026 · 14
DOI: 10.3389/fpubh.2026.1816280 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Public Health, online erschienen am 08.07.2026. Verfasst von Thanisa Thathong und 5 weiteren Autor:innen. Beteiligte Einrichtung: Social and Administrative Pharmacy Department, Faculty of Pharmaceutical Sciences, Chulalongkorn University, Bangkok, Thailand. Hauptthemen laut MEDLINE: Technology Assessment, Biomedical, Health Policy. Die Arbeit nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
Health Technology Assessment (HTA) is widely used for evidence-informed priority setting in Thailand and has been integrated into pharmaceutical reimbursement decision-making through the National List of Essential Medicines (NLEM). However, its broader contributions have not been systematically assessed.
Methods
We retrospectively analyzed 68 completed economic evaluations conducted between 2010 and 2018 using an adapted Payback Framework across five dimensions of impact: informing policy, knowledge production, capacity building, health sector benefit, and an economic dimension assessed separately for approved and rejected items using Net Monetary Benefit (NMB).
Results
The principal finding concerns the economic dimension. Among 21 approved technologies, 12 (57.1%) had negative NMB at the national cost-effectiveness threshold, suggesting that adoption would not have been supported on cost-effectiveness grounds alone. Nevertheless, each of these approvals included a structured non-cost-effectiveness justification in committee deliberations, all of which mapped to recognized multi-criteria decision analysis domains, including severity, unmet clinical need, rarity, lack of alternatives, and standard-of-care positioning. This provides empirical evidence that deliberative multi-criteria reasoning operates in routine reimbursement practice in an institutionalized LMIC HTA-to-reimbursement pathway. Among 47 rejected items, 85.1% had positive modeled NMB under a non-adoption sign convention, indicating that non-adoption was consistent with efficient resource use at the threshold. The four categorical dimensions, on a 0-4 ordinal scale, characterized the cohort along complementary axes: informing policy (mean 3.34), health sector benefit (mean 2.54), capacity building (mean 1.97), and knowledge production (mean 1.87).
Discussion
These findings suggest that HTA in Thailand contributes to disciplined, transparent multi-criteria priority setting. Aggregate NMB was concentrated in a few large-population, lifetime-horizon studies (14 accounting for 93.6% of the lifetime-horizon total), best interpreted as a descriptive summary rather than a uniform signal. The analytic approach may other insights for other low- and middle-income countries institutionalizing HTA within structured reimbursement systems.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Social and Administrative Pharmacy Department, Faculty of Pharmaceutical Sciences, Chulalongkorn University, Bangkok, Thailand.
- Food and Drug Administration, Ministry of Public Health, Nonthaburi, Thailand.
- Social and Administrative Pharmacy Department, Faculty of Pharmaceutical Sciences, Prince of Songkla University, Songkhla, Thailand.
- Social and Administrative Pharmacy Department, Faculty of Pharmaceutical Sciences, Khon Kaen University, Khon Kaen, Thailand.
- Social and Administrative Pharmacy Department, School of Pharmacy, Eastern Asia University, Pathum Thani, Thailand.
- Siriraj Health Policy Unit, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.
Zitieren
APA
Thathong, T., Udomaksorn, K., Kessomboon, N., Nerapusee, O., Leelahavarong, P., & Sakulbumrungsil, R. C. (2026). Supporting evidence-informed policy: a multidimensional impact analysis of health technology assessment in Thailand. Frontiers in Public Health, 14. https://doi.org/10.3389/fpubh.2026.1816280
Vancouver
Thathong T, Udomaksorn K, Kessomboon N, Nerapusee O, Leelahavarong P, Sakulbumrungsil RC. Supporting evidence-informed policy: a multidimensional impact analysis of health technology assessment in Thailand. Frontiers in Public Health. 2026;14. doi:10.3389/fpubh.2026.1816280
BibTeX
@article{Thathong2026,
author = {Thathong, Thanisa and Udomaksorn, Khunjira and Kessomboon, Nusaraporn and Nerapusee, Osot and Leelahavarong, Pattara and Sakulbumrungsil, Rungpetch C},
title = {Supporting evidence-informed policy: a multidimensional impact analysis of health technology assessment in Thailand},
journal = {Frontiers in Public Health},
year = {2026},
volume = {14},
doi = {10.3389/fpubh.2026.1816280}
}
EUVIMED